A study on negative and depressive symptom prevalence in individuals at ultra‐high risk for psychosis
Authors:
- 21 September 2016
- journal article
- research article
- Published by Wiley in Early Intervention in Psychiatry
- Vol. 12 (5) , 900-906
Abstract
Background: Negative symptoms are known to be present in the prodromal stage of psychotic disorders, yet little is known about their prevalence. Studies examining the presence of negative symptoms in ultra‐high risk (UHR) populations have shown some limitations, notably failing to control depression. The objective of this study was to examine the prevalence of negative symptoms in the presence of significant levels of depression and in the absence of such symptoms (primary negative symptoms) over 1 year and to examine differences in negative symptoms in psychosis converters and non‐converters.Methods: Participants were 123 individuals at UHR for the development of psychosis receiving follow‐up for a period of 2 years. Negative symptoms and depression were measured using the Scale for the Assessment of Negative Symptoms and the Montgomery‐Asberg Depression Scale at baseline, 6 and 12 months post‐admission.Results: At baseline, the prevalence of negative symptoms and primary negative symptoms was 76.4% and 32.7%, respectively. Whereas the prevalence of negative symptoms was significantly decreased at 6 months, the prevalence of primary negative symptoms was similar at all time points. Negative symptoms at baseline were not different between later converters and non‐converters to psychosis.Conclusion: Our findings confirm the presence of secondary and primary negative symptoms in individuals at UHR, but suggest a differential trajectory of both measures over time. Future studies should include larger UHR groups and focus on the investigation of intra‐individual changes in primary negative symptoms over time and further explore their potential role for psychosis conversion.Keywords
Funding Information
- Low Beer foundation
- Zubin Foundation
- Fonds de la Recherche en Santé du Québec (FRSQ)
- James McGill Professor Award
- Canada Research Chairs Program
This publication has 55 references indexed in Scilit:
- Impact of primary negative symptoms on functional outcomes in schizophreniaEuropean Psychiatry, 2014
- Depression and social anxiety in help-seeking patients with an ultra-high risk for developing psychosisPsychiatry Research, 2013
- Long-term Follow-up of a Group at Ultra High Risk (“Prodromal”) for PsychosisJAMA Psychiatry, 2013
- Negative symptoms in individuals at clinical high risk of psychosisPsychiatry Research, 2012
- Neurocognitive Indicators of Clinical High-Risk States for Psychosis: A Critical Review of the EvidenceNeurotoxicity Research, 2010
- Depression in the long-term course of schizophreniaEuropean Archives of Psychiatry and Clinical Neuroscience, 2005
- The early course of schizophrenia and depression*European Archives of Psychiatry and Clinical Neuroscience, 2005
- Choice of the primary analysis in longitudinal clinical trialsPharmaceutical Statistics, 2004
- A Longitudinal Study of Symptom Dimensions in SchizophreniaArchives of General Psychiatry, 1995
- Negative Symptoms in SchizophreniaArchives of General Psychiatry, 1982